Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
AAREYDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarey Drugs & Pharmaceuticals Limited has submitted a certificate to the stock exchange as required under the SEBI (Depositories and Participants) Regulations, 2018. This is a routine compliance filing, typically related to confirming the reconciliation of the company's issued share capital with the records held by depositories (NSDL/CDSL). No new financial numbers, business updates, or changes to share structure have been mentioned. The filing is purely procedural and meant to ensure the company's securities records remain in good standing.
This is a routine regulatory compliance submission with no direct impact on shareholders, earnings, or the company's stock price. Investors need not take any action.